Dataset | double_gel_and_single_gel_rma_expression_values_collapsed_to_symbols.class.cls #double_gel_8d_versus_double_gel_48h.class.cls #double_gel_8d_versus_double_gel_48h_repos |
Phenotype | class.cls#double_gel_8d_versus_double_gel_48h_repos |
Upregulated in class | double_gel_8d |
GeneSet | CMV_ALL_DN |
Enrichment Score (ES) | 0.566964 |
Normalized Enrichment Score (NES) | 1.9310943 |
Nominal p-value | 0.0 |
FDR q-value | 0.009009063 |
FWER p-Value | 0.473 |
PROBE | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
---|---|---|---|---|---|---|---|
1 | COL1A2 | COL1A2 Entrez,  Source | collagen, type I, alpha 2 | 6 | 1.154 | 0.1151 | Yes |
2 | ANXA1 | ANXA1 Entrez,  Source | annexin A1 | 11 | 0.884 | 0.2033 | Yes |
3 | COL3A1 | COL3A1 Entrez,  Source | collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) | 21 | 0.785 | 0.2813 | Yes |
4 | COL5A2 | COL5A2 Entrez,  Source | collagen, type V, alpha 2 | 34 | 0.714 | 0.3518 | Yes |
5 | SERPINE1 | SERPINE1 Entrez,  Source | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 56 | 0.628 | 0.4131 | Yes |
6 | ADM | ADM Entrez,  Source | adrenomedullin | 96 | 0.523 | 0.4625 | Yes |
7 | CFD | CFD Entrez,  Source | complement factor D (adipsin) | 228 | 0.365 | 0.4892 | Yes |
8 | TIMP3 | TIMP3 Entrez,  Source | TIMP metallopeptidase inhibitor 3 (Sorsby fundus dystrophy, pseudoinflammatory) | 329 | 0.291 | 0.5108 | Yes |
9 | LAMB2 | LAMB2 Entrez,  Source | laminin, beta 2 (laminin S) | 433 | 0.249 | 0.5280 | Yes |
10 | COL6A2 | COL6A2 Entrez,  Source | collagen, type VI, alpha 2 | 658 | 0.195 | 0.5307 | Yes |
11 | COL1A1 | COL1A1 Entrez,  Source | collagen, type I, alpha 1 | 673 | 0.190 | 0.5487 | Yes |
12 | IGF2 | IGF2 Entrez,  Source | insulin-like growth factor 2 (somatomedin A) | 682 | 0.188 | 0.5670 | Yes |
13 | SULT1E1 | SULT1E1 Entrez,  Source | sulfotransferase family 1E, estrogen-preferring, member 1 | 908 | 0.156 | 0.5656 | No |
14 | EPO | EPO Entrez,  Source | erythropoietin | 1235 | 0.125 | 0.5535 | No |
15 | BMP4 | BMP4 Entrez,  Source | bone morphogenetic protein 4 | 1506 | 0.108 | 0.5440 | No |
16 | HSD17B2 | HSD17B2 Entrez,  Source | hydroxysteroid (17-beta) dehydrogenase 2 | 1528 | 0.107 | 0.5531 | No |
17 | DDR2 | DDR2 Entrez,  Source | discoidin domain receptor family, member 2 | 1598 | 0.103 | 0.5582 | No |
18 | RALGDS | RALGDS Entrez,  Source | ral guanine nucleotide dissociation stimulator | 1715 | 0.097 | 0.5591 | No |
19 | IGFBP2 | IGFBP2 Entrez,  Source | insulin-like growth factor binding protein 2, 36kDa | 1859 | 0.090 | 0.5574 | No |
20 | CEBPD | CEBPD Entrez,  Source | CCAAT/enhancer binding protein (C/EBP), delta | 1977 | 0.086 | 0.5571 | No |
21 | ACTA2 | ACTA2 Entrez,  Source | actin, alpha 2, smooth muscle, aorta | 2074 | 0.082 | 0.5581 | No |
22 | IGF1R | IGF1R Entrez,  Source | insulin-like growth factor 1 receptor | 2201 | 0.077 | 0.5564 | No |
23 | ZFP36L1 | ZFP36L1 Entrez,  Source | zinc finger protein 36, C3H type-like 1 | 2445 | 0.070 | 0.5450 | No |
24 | AR | AR Entrez,  Source | androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease) | 2477 | 0.069 | 0.5495 | No |
25 | CCND1 | CCND1 Entrez,  Source | cyclin D1 | 2668 | 0.063 | 0.5416 | No |
26 | SGCG | SGCG Entrez,  Source | sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) | 2905 | 0.057 | 0.5295 | No |
27 | TGFBR3 | TGFBR3 Entrez,  Source | transforming growth factor, beta receptor III (betaglycan, 300kDa) | 3034 | 0.054 | 0.5252 | No |
28 | ACO1 | ACO1 Entrez,  Source | aconitase 1, soluble | 3097 | 0.052 | 0.5257 | No |
29 | HNMT | HNMT Entrez,  Source | histamine N-methyltransferase | 3098 | 0.052 | 0.5309 | No |
30 | CXCR7 | CXCR7 Entrez,  Source | chemokine (C-X-C motif) receptor 7 | 3953 | 0.034 | 0.4699 | No |
31 | CHN1 | CHN1 Entrez,  Source | chimerin (chimaerin) 1 | 4021 | 0.032 | 0.4681 | No |
32 | FGF7 | FGF7 Entrez,  Source | fibroblast growth factor 7 (keratinocyte growth factor) | 4156 | 0.030 | 0.4611 | No |
33 | RAB13 | RAB13 Entrez,  Source | RAB13, member RAS oncogene family | 4159 | 0.030 | 0.4639 | No |
34 | IGFBP5 | IGFBP5 Entrez,  Source | insulin-like growth factor binding protein 5 | 4507 | 0.023 | 0.4401 | No |
35 | PTGIS | PTGIS Entrez,  Source | prostaglandin I2 (prostacyclin) synthase | 4653 | 0.021 | 0.4312 | No |
36 | TNFRSF1A | TNFRSF1A Entrez,  Source | tumor necrosis factor receptor superfamily, member 1A | 4825 | 0.018 | 0.4202 | No |
37 | NR3C1 | NR3C1 Entrez,  Source | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 5227 | 0.011 | 0.3911 | No |
38 | CXCL12 | CXCL12 Entrez,  Source | chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) | 5302 | 0.010 | 0.3865 | No |
39 | MAPK14 | MAPK14 Entrez,  Source | mitogen-activated protein kinase 14 | 5554 | 0.007 | 0.3683 | No |
40 | NR2F2 | NR2F2 Entrez,  Source | nuclear receptor subfamily 2, group F, member 2 | 5565 | 0.006 | 0.3681 | No |
41 | ENG | ENG Entrez,  Source | endoglin (Osler-Rendu-Weber syndrome 1) | 5761 | 0.003 | 0.3538 | No |
42 | WEE1 | WEE1 Entrez,  Source | WEE1 homolog (S. pombe) | 5905 | 0.001 | 0.3431 | No |
43 | ACVR2A | ACVR2A Entrez,  Source | activin A receptor, type IIA | 5960 | 0.001 | 0.3391 | No |
44 | PDGFRA | PDGFRA Entrez,  Source | platelet-derived growth factor receptor, alpha polypeptide | 6101 | -0.002 | 0.3287 | No |
45 | MATK | MATK Entrez,  Source | megakaryocyte-associated tyrosine kinase | 6298 | -0.005 | 0.3144 | No |
46 | BCL2 | BCL2 Entrez,  Source | B-cell CLL/lymphoma 2 | 6363 | -0.006 | 0.3102 | No |
47 | CRHBP | CRHBP Entrez,  Source | corticotropin releasing hormone binding protein | 6512 | -0.008 | 0.2998 | No |
48 | THBS2 | THBS2 Entrez,  Source | thrombospondin 2 | 6731 | -0.011 | 0.2845 | No |
49 | ANPEP | ANPEP Entrez,  Source | alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13, p150) | 6961 | -0.014 | 0.2687 | No |
50 | CDH11 | CDH11 Entrez,  Source | cadherin 11, type 2, OB-cadherin (osteoblast) | 7101 | -0.017 | 0.2599 | No |
51 | TPM1 | TPM1 Entrez,  Source | tropomyosin 1 (alpha) | 7114 | -0.017 | 0.2607 | No |
52 | HIVEP2 | HIVEP2 Entrez,  Source | human immunodeficiency virus type I enhancer binding protein 2 | 7650 | -0.025 | 0.2229 | No |
53 | CYP1B1 | CYP1B1 Entrez,  Source | cytochrome P450, family 1, subfamily B, polypeptide 1 | 7989 | -0.031 | 0.2005 | No |
54 | EFEMP1 | EFEMP1 Entrez,  Source | EGF-containing fibulin-like extracellular matrix protein 1 | 8124 | -0.033 | 0.1937 | No |
55 | ANP32A | ANP32A Entrez,  Source | acidic (leucine-rich) nuclear phosphoprotein 32 family, member A | 8654 | -0.041 | 0.1579 | No |
56 | C1R | C1R Entrez,  Source | complement component 1, r subcomponent | 8819 | -0.044 | 0.1500 | No |
57 | MARCKS | MARCKS Entrez,  Source | myristoylated alanine-rich protein kinase C substrate | 8955 | -0.047 | 0.1445 | No |
58 | CSPG2 | CSPG2 Entrez,  Source | chondroitin sulfate proteoglycan 2 (versican) | 9690 | -0.060 | 0.0951 | No |
59 | AHR | AHR Entrez,  Source | aryl hydrocarbon receptor | 9715 | -0.060 | 0.0994 | No |
60 | CDC25B | CDC25B Entrez,  Source | cell division cycle 25B | 9872 | -0.064 | 0.0940 | No |
61 | ZCCHC9 | ZCCHC9 Entrez,  Source | zinc finger, CCHC domain containing 9 | 9937 | -0.065 | 0.0957 | No |
62 | PAFAH1B1 | PAFAH1B1 Entrez,  Source | platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit 45kDa | 10930 | -0.089 | 0.0298 | No |
63 | PABPC1 | PABPC1 Entrez,  Source | poly(A) binding protein, cytoplasmic 1 | 11058 | -0.092 | 0.0295 | No |
64 | ITSN1 | ITSN1 Entrez,  Source | intersectin 1 (SH3 domain protein) | 11216 | -0.096 | 0.0273 | No |
65 | ADRA2A | ADRA2A Entrez,  Source | adrenergic, alpha-2A-, receptor | 11237 | -0.097 | 0.0354 | No |
66 | RUNX1 | RUNX1 Entrez,  Source | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 11329 | -0.100 | 0.0386 | No |
67 | MYH9 | MYH9 Entrez,  Source | myosin, heavy chain 9, non-muscle | 11636 | -0.111 | 0.0266 | No |
68 | DDIT4 | DDIT4 Entrez,  Source | DNA-damage-inducible transcript 4 | 11645 | -0.111 | 0.0371 | No |
69 | TSPAN6 | TSPAN6 Entrez,  Source | tetraspanin 6 | 12255 | -0.140 | 0.0052 | No |
70 | AARS | AARS Entrez,  Source | alanyl-tRNA synthetase | 12282 | -0.141 | 0.0174 | No |
71 | ID2 | ID2 Entrez,  Source | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 12777 | -0.181 | -0.0016 | No |
72 | GPX1 | GPX1 Entrez,  Source | glutathione peroxidase 1 | 12783 | -0.183 | 0.0163 | No |
73 | MBL2 | MBL2 Entrez,  Source | mannose-binding lectin (protein C) 2, soluble (opsonic defect) | 13116 | -0.257 | 0.0170 | No |